截至2025年7月8日15时，泽璟制药-U股价报112.60元，较前一交易日下跌2.60元。当日开盘价为114.58元，最高触及117.98元，最低下探至112.20元，成交量为34955手，成交金额达3.99亿元。
泽璟制药-U属于科创板医药生物板块企业，专注于肿瘤、出血及血液疾病、免疫炎症性疾病等领域的创新药物研发。公司采用精准小分子药物研发及产业化平台和复杂重组蛋白新药研发及产业化平台双轮驱动模式。
数据显示，科创板市场目前共有39只百元股，其中医药生物行业占据8席。在当日交易中，泽璟制药-U主力资金净流出5647.52万元。
风险提示：股市有风险，投资需谨慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.